Actinium Pharmaceuticals, Inc.
For the period ended Nov 26, 2025. Filed Nov 26, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Nov 26, 2025 · Filed Nov 26, 2025
Use the contents to explore the available documents and sections.
ATNM$1.43+10.0%Stored close · as of Nov 6, 2026
Contents
Cover page
Show cover page
**UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.